• Continuous Subcutaneous Insulin Infusion therapy (CSII) can improve glycemic control in patients with Type-1 Diabetes as observed in several studies.
Background
• Continuous Subcutaneous Insulin Infusion therapy (CSII) can improve glycemic control in patients with Type-1 Diabetes as observed in several studies.
• However, there are very few studies comparing glycaemic control in patients with different basal rates on CSII, so the ideal number of basal rates for a patient is not clear.
Results
• 75 patients were evaluated.
• 46(61.3%) were female.
• All had type-1 diabetes except for 2 (1 had type-2 diabetes and the other had diabetes secondary to pancreatic disease).
• Patients were divided in two groups based on those using <5 basal rates and on ≥5 basal rates over 24 hours.
• There were 33 patients in the group on <5 basal rates, 63% were female. Mean age was 42.7±10.3 (mean±SD) years with a BMI of 25.9±3.4 kg/m2. Duration of DM was 19.3±11.0 years and on CSII for 5.5±3.4 years. 30% patients had impaired awareness of hypoglycaemia, 51.5% used temporary (basal) rates and 72.7% used bolus calculator.
• There were 42 patients in the group on ≥5 basal rates, 54.5% were female. Mean age was 38.7±9.3 years with a BMI of 25.9±4.6 kg/m2. Duration of DM was 19.3±9.5 years and of CSII was 4.9±2.9 years. 27.2% patients had impaired awareness of hypoglycemia. 63.2% used temporary (basal) rates and 63.6% used bolus calculator.
• In both groups, similar number of patients (69.6%) experienced at least one episode of hypoglycaemia on average per week.
• Mean HbA1c in those on <5 basal rates was 7.8 
Conclusion
In our study there was no difference in glycaemic control between the patients on fewer(<5) or more(≥5) basal rates. The characteristics of both groups were similar so advice on the optimal number of basal rates for a patient appears to vary from individual to individual.
Objective
• To compare the glycaemic control between patients with different basal rates.
Methods
• Data was collected from hospital's database (CELLMA) and by contacting patients via phone.
